276
Views
84
CrossRef citations to date
0
Altmetric
Review

Tailoring antibodies for radionuclide delivery

&
Pages 53-70 | Published online: 22 Dec 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Simon Krah, Christian Schröter, Stefan Zielonka, Martin Empting, Bernhard Valldorf & Harald Kolmar. (2016) Single-domain antibodies for biomedical applications. Immunopharmacology and Immunotoxicology 38:1, pages 21-28.
Read now
Stefan Zielonka, Martin Empting, Julius Grzeschik, Doreen Könning, Caroline J Barelle & Harald Kolmar. (2015) Structural insights and biomedical potential of IgNAR scaffolds from sharks. mAbs 7:1, pages 15-25.
Read now
Claudia T Mendler, Lars Friedrich, Iina Laitinen, Martin Schlapschy, Markus Schwaiger, Hans-Jürgen Wester & Arne Skerra. (2015) High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation. mAbs 7:1, pages 96-109.
Read now
Fei-Fei Teng, Xue Meng, Xin-Dong Sun & Jin-Ming Yu. (2013) New strategy for monitoring targeted therapy: molecular imaging. International Journal of Nanomedicine 8, pages 3703-3713.
Read now
Lieven Huang, Serge Muyldermans & Dirk Saerens. (2010) Nanobodies®: proficient tools in diagnostics. Expert Review of Molecular Diagnostics 10:6, pages 777-785.
Read now
Andreas M Hohlbaum & Arne Skerra. (2007) Anticalins®: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies. Expert Review of Clinical Immunology 3:4, pages 491-501.
Read now

Articles from other publishers (78)

Elif Tugce SARCAN & Yekta ÖZER. (2023) Monoclonal Antibodies and Immuno-PET Imaging: An Overview. Fabad Journal of Pharmaceutical Sciences.
Crossref
Charles Wynter, Navya Murugesan & Arutselvan Natarajan. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 34 .
Yang Wang, Wenjie Yuan, Siqi Guo, Qiqi Li, Xiaomei Chen, Cheng Li, Qianying Liu, Lei Sun, Zhenguo Chen, Zhenghong Yuan, Cheng Luo, Shijie Chen, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2022) A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments. Nature Communications 13:1.
Crossref
Reyhaneh Manafi-Farid, Bahar Ataeinia, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Mohammad Mobin Moradi, Christian Pirich & Mohsen Beheshti. (2022) ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. Frontiers in Medicine 9.
Crossref
Sana Arnouk, Timo W.M. De Groof & Jo A. Van Ginderachter. (2022) Imaging and therapeutic targeting of the tumor immune microenvironment with biologics. Advanced Drug Delivery Reviews 184, pages 114239.
Crossref
Xue Qin, Xiangxi Meng, Yao Xiong, Xiaoyi Guo, Yanan Ren, Li Wen, Qian Zhang, Hua Zhu & Zhi Yang. (2022) Initial evaluation of 99m Tc‐labeled anti‐carcinoembryonic antigen single‐chain fragment variable for micro‐single‐photon emission computed tomography imaging in mice with colorectal cancer . Journal of Labelled Compounds and Radiopharmaceuticals 65:3, pages 63-70.
Crossref
Nidhi Mishra, Neelu Singh & Poonam Parashar. 2022. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases 103 125 .
Yongsheng Liu, Anzhelika Vorobyeva, Tianqi Xu, Anna Orlova, Annika Loftenius, Theresa Bengtsson, Per Jonasson, Vladimir Tolmachev & Fredrik Y. Frejd. (2021) Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain. Pharmaceutics 13:6, pages 839.
Crossref
Anna M. Wu. 2021. Molecular Imaging. Molecular Imaging 753 770 .
João C. S. Simões, Sophia Sarpaki, Panagiotis Papadimitroulas, Bruno Therrien & George Loudos. (2020) Conjugated Photosensitizers for Imaging and PDT in Cancer Research. Journal of Medicinal Chemistry 63:23, pages 14119-14150.
Crossref
Weijun Wei, Zachary T. Rosenkrans, Jianjun Liu, Gang Huang, Quan-Yong Luo & Weibo Cai. (2020) ImmunoPET: Concept, Design, and Applications. Chemical Reviews 120:8, pages 3787-3851.
Crossref
Javad Garousi, Sarah Lindbo, Jesper Borin, Emma von Witting, Anzhelika Vorobyeva, Maryam Oroujeni, Bogdan Mitran, Anna Orlova, Jos Buijs, Vladimir Tolmachev & Sophia Hober. (2019) Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours. European Journal of Pharmaceutics and Biopharmaceutics 134, pages 37-48.
Crossref
Shen Jing, Yujia He, Yanqiong He, Liang Wang, Jianhua Jia, Xiaomin Shan, Shuang Liu, Min Tang, Zhiping Peng & Xujie Liu. (2018) Imaging Potential Evaluation of Fab Derived from the Anti-EGFRvIII Monoclonal Antibody 4G1. Radiation Research 190:2, pages 194-203.
Crossref
Anzhelika Vorobyeva, Kristina Westerlund, Bogdan Mitran, Mohamed Altai, Sara Rinne, Jens Sörensen, Anna Orlova, Vladimir Tolmachev & Amelie Eriksson Karlström. (2018) Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy. Scientific Reports 8:1.
Crossref
Chiuan Herng Leow, Qin Cheng, Katja Fischer & James McCarthy. 2018. Antibody Engineering. Antibody Engineering.
P. M. Peiris, F. He, G. Covarrubias, S. Raghunathan, O. Turan, M. Lorkowski, B. Gnanasambandam, C. Wu, W. P. Schiemann & E. Karathanasis. (2018) Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands. Nanoscale 10:15, pages 6861-6871.
Crossref
Davinia Ryan & Lisa Bodei. (2017) Radioimmunotherapy in Oncology. Current Radiology Reports 5:12.
Crossref
Chiuan Leow, Katja Fischer, Chiuan Leow, Qin Cheng, Candy Chuah & James McCarthy. (2017) Single Domain Antibodies as New Biomarker Detectors. Diagnostics 7:4, pages 52.
Crossref
H. Pye, M. A. Butt, H. W. Reinert, A. Maruani, J. P. M. Nunes, J. S. Marklew, M. Qurashi, L. Funnell, A. May, I. Stamati, R. Hamoudi, J. R. Baker, M. E. B. Smith, S. Caddick, M. P. Deonarain, G. Yahioglu, V. Chudasama & L. B. Lovat. (2016) A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy. Photochemical & Photobiological Sciences 15:10, pages 1227-1238.
Crossref
Fei-Fei AnMark ChanHarikrishna KommidiRichard Ting. (2016) Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology. American Journal of Roentgenology 207:2, pages 266-273.
Crossref
Hisataka Kobayashi, Peter L Choyke & Mikako Ogawa. (2016) Monoclonal antibody-based optical molecular imaging probes; considerations and caveats in chemistry, biology and pharmacology. Current Opinion in Chemical Biology 33, pages 32-38.
Crossref
Erik A. Rodriguez, Ye Wang, Jessica L. Crisp, David R. Vera, Roger Y. Tsien & Richard Ting. (2016) New Dioxaborolane Chemistry Enables [ 18 F]-Positron-Emitting, Fluorescent [ 18 F]-Multimodality Biomolecule Generation from the Solid Phase . Bioconjugate Chemistry 27:5, pages 1390-1399.
Crossref
Sarah Lindbo, Javad Garousi, Mikael Åstrand, Hadis Honarvar, Anna Orlova, Sophia Hober & Vladimir Tolmachev. (2016) Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins. Bioconjugate Chemistry 27:3, pages 716-726.
Crossref
Joseph Gerard Jurcic, Jeffrey Y.C. Wong, Susan J. Knox, Daniel R. Wahl, Todd L. Rosenblat & Ruby F. Meredith. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 399 418.e14 .
Naoya Kondo, Takashi Temma, Yoichi Shimizu, Masahiro Ono & Hideo Saji. (2015) Radioiodinated Peptidic Imaging Probes for <i>in Vivo</i> Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:9, pages 1375-1382.
Crossref
Mohamed Altai, Helena Wållberg, Hadis Honarvar, Joanna Strand, Anna Orlova, Zohreh Varasteh, Mattias Sandström, John Löfblom, Erik Larsson, Sven-Erik Strand, Mark Lubberink, Stefan Ståhl & Vladimir Tolmachev. (2014) 188 Re-Z HER2:V2 , a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment . Journal of Nuclear Medicine 55:11, pages 1842-1848.
Crossref
Mohamed Altai, Hadis Honarvar, Helena Wållberg, Joanna Strand, Zohreh Varasteh, Maria Rosestedt, Anna Orlova, Finn Dunås, Mattias Sandström, John Löfblom, Vladimir Tolmachev & Stefan Ståhl. (2014) Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re. European Journal of Medicinal Chemistry 87, pages 519-528.
Crossref
Karen Alt, Brett M. Paterson, Katie Ardipradja, Christine Schieber, Gojko Buncic, Bock Lim, Stan S. Poniger, Bjoern Jakoby, Xiaowei Wang, Graeme J. O’Keefe, Henri J. Tochon-Danguy, Andrew M. Scott, Uwe Ackermann, Karlheinz Peter, Paul S. Donnelly & Christoph E. Hagemeyer. (2014) Single-Chain Antibody Conjugated to a Cage Amine Chelator and Labeled with Positron-Emitting Copper-64 for Diagnostic Imaging of Activated Platelets. Molecular Pharmaceutics 11:8, pages 2855-2863.
Crossref
Katie Ardipradja, Shinn Dee Yeoh, Karen Alt, Graeme O’Keefe, Angela Rigopoulos, David W. Howells, Andrew M. Scott, Karlheinz Peter, Uwe Ackerman & Christoph E. Hagemeyer. (2014) Detection of activated platelets in a mouse model of carotid artery thrombosis with 18F-labeled single-chain antibodies. Nuclear Medicine and Biology 41:3, pages 229-237.
Crossref
E. Eggenstein, A. Eichinger, H.-J. Kim & A. Skerra. (2014) Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy. Journal of Structural Biology 185:2, pages 203-214.
Crossref
Mark D. Girgis, Noah Federman, Matthew M. Rochefort, Katelyn E. McCabe, Anna M. Wu, Jon O. Nagy, Christopher Denny & James S. Tomlinson. (2013) An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles. Journal of Surgical Research 185:1, pages 45-55.
Crossref
Hayley Pye, Ioanna Stamati, Gokhan Yahioglu, M. Butt & Mahendra Deonarain. (2013) Antibody-Directed Phototherapy (ADP). Antibodies 2:4, pages 270-305.
Crossref
Michaela Gebauer, André Schiefner, Gabriele Matschiner & Arne Skerra. (2013) Combinatorial Design of an Anticalin Directed against the Extra-Domain B for the Specific Targeting of Oncofetal Fibronectin. Journal of Molecular Biology 425:4, pages 780-802.
Crossref
Diana Gil & Adam G. Schrum. (2013) Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments. Advances in Bioscience and Biotechnology 04:04, pages 73-84.
Crossref
Brian M. Zeglis, Jason P. Holland, Artem Y. Lebedev, Melchor V. Cantorias & Jason S. Lewis. 2013. Nuclear Oncology. Nuclear Oncology 35 78 .
Seyed Jalal Hosseinimehr, Vladimir Tolmachev & Anna Orlova. (2012) Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design. Drug Discovery Today 17:21-22, pages 1224-1232.
Crossref
Stefano Menegatti, Amith D. Naik, Patrick V. Gurgel & Ruben G. Carbonell. (2012) Purification of polyclonal antibodies from Cohn fraction II + III, skim milk, and whey by affinity chromatography using a hexamer peptide ligand. Journal of Separation Science 35:22, pages 3139-3148.
Crossref
Marie Ranson, Paula Berghofer, Kara L. Vine, Ivan Greguric, Rachael Shepherd & Andrew Katsifis. (2012) Different radiolabelling methods alter the pharmacokinetic and biodistribution properties of Plasminogen Activator Inhibitor Type 2 (PAI-2) forms. Nuclear Medicine and Biology 39:6, pages 833-839.
Crossref
Jan Terje Andersen, Stian Foss, Vania E. Kenanova, Tove Olafsen, Ingvild S. Leikfoss, Derry C. Roopenian, Anna M. Wu & Inger Sandlie. (2012) Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life. Journal of Biological Chemistry 287:27, pages 22927-22937.
Crossref
Gabriella Fanali, Alessandra di Masi, Viviana Trezza, Maria Marino, Mauro Fasano & Paolo Ascenzi. (2012) Human serum albumin: From bench to bedside. Molecular Aspects of Medicine 33:3, pages 209-290.
Crossref
Ruby F. Meredith, Jeffrey Y.C. Wong & Susan J. Knox. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology e22-1 e22-46 .
Joachim Feldwisch & Vladimir Tolmachev. 2012. Therapeutic Proteins. Therapeutic Proteins 103 126 .
David M. Goldenberg & Robert M. Sharkey. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 125 138 .
Mark D Girgis, Tove Olafsen, Vania Kenanova, Katelyn E McCabe, Anna M Wu & James S Tomlinson. (2011) Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment. EJNMMI Research 1:1.
Crossref
Martina Steiner & Dario Neri. (2011) Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends. Clinical Cancer Research 17:20, pages 6406-6416.
Crossref
Mark D. Girgis, Vania Kenanova, Tove Olafsen, Katelyn E. McCabe, Anna M. Wu & James S. Tomlinson. (2011) Anti-CA19-9 Diabody as a PET Imaging Probe for Pancreas Cancer. Journal of Surgical Research 170:2, pages 169-178.
Crossref
Vladimir Tolmachev, Joachim Feldwisch, Malin Lindborg, Barbro Baastrup, Mattias Sandström & Anna Orlova. (2011) Influence of an aliphatic linker between DOTA and synthetic ZHER2:342 Affibody molecule on targeting properties of the 111In-labeled conjugate. Nuclear Medicine and Biology 38:5, pages 697-706.
Crossref
Jesse V. Jokerst, Jie Chou, James P. Camp, Jorge Wong, Alexis Lennart, Amanda A. Pollard, Pierre N. Floriano, Nicolaos Christodoulides, Glennon W. Simmons, Yanjie Zhou, Mehnaaz F. Ali & John T. McDevitt. (2011) Location of Biomarkers and Reagents within Agarose Beads of a Programmable Bio-nano-chip. Small 7:5, pages 613-624.
Crossref
Lauren T Rosenblum, Peter L Choyke & Hisataka Kobayashi. (2011) Quantitative and specific molecular imaging of cancer with labeled engineered monoclonal antibody fragments. Therapeutic Delivery 2:3, pages 345-358.
Crossref
Mark D. Girgis, Tove Olafsen, Vania Kenanova, Katelyn E. McCabe, Anna M. Wu & James S. Tomlinson. (2011) CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer. International Journal of Molecular Imaging 2011, pages 1-9.
Crossref
Vladimir Tolmachev, Camilla Hofström, Jennie Malmberg, Sara Ahlgren, Seyed Jalal Hosseinimehr, Mattias Sandström, Lars Abrahmsén, Anna Orlova & Torbjörn Gräslund. (2010) HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [ 99m Tc(CO) 3 ] + , and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation . Bioconjugate Chemistry 21:11, pages 2013-2022.
Crossref
Robert M. Sharkey & David G. Goldenberg. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer 241 287 .
Sara Ahlgren, Anna Orlova, Helena Wållberg, Monika Hansson, Mattias Sandström, Richard Lewsley, Anders Wennborg, Lars Abrahmsén, Vladimir Tolmachev & Joachim Feldwisch. (2010) Targeting of HER2 -Expressing Tumors Using 111 In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold . Journal of Nuclear Medicine 51:7, pages 1131-1138.
Crossref
Sara Ahlgren, Kristofer Andersson & Vladimir Tolmachev. (2010) Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine. Nuclear Medicine and Biology 37:5, pages 539-546.
Crossref
Syd Johnson, Stephen Burke, Ling Huang, Sergey Gorlatov, Hua Li, Weili Wang, Wenjun Zhang, Nadine Tuaillon, Jonah Rainey, Bhaswati Barat, Yinhua Yang, Linda Jin, Valentina Ciccarone, Paul A. Moore, Scott Koenig & Ezio Bonvini. (2010) Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion. Journal of Molecular Biology 399:3, pages 436-449.
Crossref
Robert M. Sharkey, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang & David M. Goldenberg. (2010) Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy. Seminars in Nuclear Medicine 40:3, pages 190-203.
Crossref
Anna Orlova, Thuy A. Tran, Torun Ekblad, Amelie Eriksson Karlström & Vladimir Tolmachev. (2009) 186Re-maSGS-ZHER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumours. European Journal of Nuclear Medicine and Molecular Imaging 37:2, pages 260-269.
Crossref
Talal Al Saati & Pierre Brousset. (2010) Données récentes sur la production d’anticorps monoclonaux à visée diagnostique en histopathologie. Revue Francophone des Laboratoires 2010:418, pages 51-55.
Crossref
Justin Chan, Jayant P. Menon, Rohit Mahajan & Rahul Jandial. 2010. Frontiers in Brain Repair. Frontiers in Brain Repair 1 12 .
Hao Hong, Yin Zhang, Jiangtao Sun & Weibo Cai. (2009) Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 4:5, pages 399-413.
Crossref
Bhaswati BaratShannon J. SirkKatelyn E. McCabeJianqing LiEric J. LepinRoland RemenyiAi Leen KohTove OlafsenSanjiv S. GambhirShimon WeissAnna M. Wu. (2009) Cys-diabody Quantum Dot Conjugates (ImmunoQdots) for Cancer Marker Detection. Bioconjugate Chemistry 20:8, pages 1474-1481.
Crossref
Vladimir Tolmachev, Eskender Mume, Stefan Sjöberg, Fredrik Y. Frejd & Anna Orlova. (2008) Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules. European Journal of Nuclear Medicine and Molecular Imaging 36:4, pages 692-701.
Crossref
Hyun Jin Kim, Andreas Eichinger & Arne Skerra. (2009) High-Affinity Recognition of Lanthanide(III) Chelate Complexes by a Reprogrammed Human Lipocalin 2. Journal of the American Chemical Society 131:10, pages 3565-3576.
Crossref
Vladimir Tolmachev, Mikaela Friedman, Mattias Sandström, Tove L.J. Eriksson, Daniel Rosik, Monika Hodik, Stefan Ståhl, Fredrik Y. Frejd & Anna Orlova. (2009) Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry. Journal of Nuclear Medicine 50:2, pages 274-283.
Crossref
Jan Terje Andersen & Inger Sandlie. (2009) The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics. Drug Metabolism and Pharmacokinetics 24:4, pages 318-332.
Crossref
DAVID GOLDENBERG & ROBERT SHARKEY. 2008. Molecular Imaging in Oncology. Molecular Imaging in Oncology 571 584 .
Arutselvan Natarajan, Pappanaicken R. Kumaresan, Sally J. DeNardo, Gerald L. DeNardo, Gary Mirick & Kit S. Lam. (2008) Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy. Bioorganic & Medicinal Chemistry Letters 18:17, pages 4802-4805.
Crossref
Lieven Huang, Lea Olive Tchouate Gainkam, Vicky Caveliers, Chris Vanhove, Marleen Keyaerts, Patrick De Baetselier, Axel Bossuyt, Hilde Revets & Tony Lahoutte. (2008) SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression. Molecular Imaging and Biology 10:3, pages 167-175.
Crossref
Robert M. Sharkey, Habibe Karacay, Shankar Vallabhajosula, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Stanley J. Goldsmith & David M. Goldenberg. (2008) Metastatic Human Colonic Carcinoma: Molecular Imaging with Pretargeted SPECT and PET in a Mouse Model. Radiology 246:2, pages 497-507.
Crossref
Lin Li, James Bading, Paul J. Yazaki, Amitkumar H. Ahuja, Desiree Crow, David Colcher, Lawrence E. Williams, Jeffrey Y. C. Wong, Andrew Raubitschek & John E. Shively. (2007) A Versatile Bifunctional Chelate for Radiolabeling Humanized Anti-CEA Antibody with In-111 and Cu-64 at Either Thiol or Amino Groups: PET Imaging Of CEA-Positive Tumors with Whole Antibodies. Bioconjugate Chemistry 19:1, pages 89-96.
Crossref
Olaf Behrsing & Burkhard Micheel. 2008. Grundlagen der Molekularen Medizin. Grundlagen der Molekularen Medizin 449 475 .
Esteban Obenaus, Paola A. Erba, Marco Chinol, Christophe Van de Wiele, Gyozo A. Janoki, Rudy A. Dierckx, Francesco Scopinaro & Alberto Signore. 2008. Radioguided Surgery. Radioguided Surgery 3 11 .
D M Goldenberg & R M Sharkey. (2007) Novel radiolabeled antibody conjugates. Oncogene 26:25, pages 3734-3744.
Crossref
David M. Goldenberg, Robert M. Sharkey, Jacques Barbet & Jean-Francois Chatal. (2007) Radioactive antibodies: Selective targeting and treatment of cancer and other diseases. Applied Radiology, pages 10-29.
Crossref
Karin Knogler, Jürgen Grünberg, Kurt Zimmermann, Susan Cohrs, Michael Honer, Simon Ametamey, Peter Altevogt, Mina Fogel, P. August Schubiger & Ilse Novak-Hofer. (2007) Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis. Clinical Cancer Research 13:2, pages 603-611.
Crossref
Vania Kenanova, Tove Olafsen, Lawrence E. Williams, Nora H. Ruel, Jeffrey Longmate, Paul J. Yazaki, John E. Shively, David Colcher, Andrew A. Raubitschek & Anna M. Wu. (2007) Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy. Cancer Research 67:2, pages 718-726.
Crossref
Tove Olafsen, Vania E Kenanova & Anna M Wu. (2006) Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. Nature Protocols 1:4, pages 2048-2060.
Crossref
Giovanni Lucignani, Luisa Ottobrini, Cristina Martelli, Maria Rescigno & Mario Clerici. (2006) Molecular imaging of cell-mediated cancer immunotherapy. Trends in Biotechnology 24:9, pages 410-418.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.